Systemic scleroderma: A spatiotemporal clustering

Internal Medicine Journal

Volumn 35, Issue 4, 2005, Pages 228-233

  Englert, Helen ^a   Joyner, E ^b   Bade, R ^b   Thompson, M ^c   Morris, D ^d   Chambers, P ^b   Carroll, G ^e   Manolios, N ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b Statistician Stat Services Pty Ltd ^*

^c Statistician Stat Services Pty Ltd   (Australia)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

^e ArthroCare   (Australia)

Author keywords

Aetiology; Spatiotemporal cluster; Systemic scleroderma

Indexed keywords

SILICON DIOXIDE; VINYL CHLORIDE;

ADULT; AGE; ARTICLE; AUSTRALIA; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FAMILY HISTORY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; QUESTIONNAIRE; RAYNAUD PHENOMENON; SYSTEMIC SCLEROSIS;

EID: 17244362135     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2005.00783.x     Document Type: Article

References (38)

1. Sasaki T, Denpo K, Ono H, Nakajima H. HLA in systemic scleroderma (PSS) and familial scleroderma. J Dermatol 1991; 18: 18-24.
2. Briggs D, Black C, Welsh K. Genetic factors in scleroderma. Rheum Dis Clin North Am 1990; 16: 31-51.
3. Welsh KI, Briggs DC. Genetic and environmental factors in scleroderma. Curr Opin Rheumatol 1991; 3: 944-6.
4. Erasmus LD. Scleroderma in gold miners on the Witwatersrand with particular reference to pulmonary manifestations. S Afr J Lab Clin Med 1957; 3: 209-31.
5. Gunther G, Shuchardt E. Silicosis und progressive scleroderma. A unifying aetiology? Dtsch Med Wochenschr 1970; 95: 467-8.
6. Sluis-Cremer GK, Hessel PA, Nizdo EH, Churchill AR, Zeiss EA. Silica-silicosis, and progressive systemic sclerosis. Br J Ind Med 1985; 41: 838-43.
7. Haustein UF, Ziegler MD. Environmentally induced systemic sclerosis-like disorders. Int J Dermatol 1985; 24: 147-51.
8. Sanchez-Roman J, Wichmann I, Salaberri J, Varela JM, Nunez-Roldan A. Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica Ann Rheum Dis 1993; 52: 534-8.
9. Owens GR, Medsger TA. Systemic sclerosis secondary to occupational exposure. Am J Med 1988; 85: 114-16.
10. Rodnan GP, Benedek TG, Medsger TA, Cammarata RJ. The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis. Ann Intern Med 1967; 66: 323-34.
11. Gusseva NG, Folomeeva OM, Ockilko TG. Familial systemic sclerosis: a follow-up study of concordant monozygotic twins. Ter Arkh 1981; 53: 43-7.
12. Dubois EI, Chandor S, Friou GJ, Bischel M. Progressive systemic sclerosis (PSS) and localised scleroderma (morphea) with positive LE cell test and usual systemic manifestations compatible with systemic lupus erythematosus (SLE): presentation of 14 cases including one set of identical twins, one with scleroderma and the other with SLE. Review of the literature. Medicine 1971; 50: 199-222.
13. Freudenberg J, Holzmann H, Schneider S, Korting GW. HLA antigen frequencies in patients with progressive scleroderma and morphea. Arch Dermatol Res 1978; 263: 197-205.
14. Dustoor MM, McInerney MM, Mazarec DJ, Cathcart MK. Abnormal lymphocyte function in scleroderma: a study on Identical Twins. Clin Immunol 1987; 44: 20-30.
15. Cook NJ, Silman AJ, Cawley MID. Features of systemic sclerosis (scleroderma) in an identical twin pair. Br J Rheumatol 1993; 32: 926-8.
16. Fenghali-Bostwick C, Medsger TA, Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 2003; 48: 1956-63.
17. Harris DK, Adams WGF. Acroosteolysis occurring in men engaged in the polymerisation of vinyl chloride. Br Med J 1967; 3: 712-14.
18. Lange CE, Juhe S, Veltman G. The occurrence of liver angiosarcoma in 2 patients in the PVC manufacturing industry. Dtsch Med Wochenschr 1974; 99: 1598-9.
19. Ward AM, Udnoon S, Watkins J, Walker AE, Darke CS. Immunological mechanisms in the pathogenesis of vinyl chloride disease. Br Med J 1976; 1: 936-8.
20. Kissel P, Schmitt J, Barrucand D, Sapelier J. Reports of scleroderma and silicosis: an observation. Ann Med Nancy 1965; 4: 26-34.
21. Cauvet M, Matrin E. Silicose and sclerodermis. Schweiz Med Wochenschr Suppl 1969; 4: 1261-3.
22. Englert H, Small-McMahon J, Davis K, O'Connor H, Chambers P, Brooks P. Male systemic sclerosis and occupational silica exposure - a population-based study. Aust NZ J Med 2000; 30: 215-20.
23. Walder B. Solvents and scleroderma. Lancet 1965; ii: 436-7.
24. Brasington RD, Thorpe-Swenson AJ. Systemic sclerosis associated with cutaneous exposure to solvent: case report and review of the literature. Arth Rheum 1991; 34: 631-3.
25. Yamakage A, Ishikawa H, Saito Y, Hattori A. Occupational scleroderma-like disorder occurring in men engaged in the polymerisation of epoxy resins. Dermatologica 1980; 161: 44.
26. Diaz de R, Castro Garcia M, Borda A, Alonso Gordo JM, Posada de la Paz M, Kilbourne EM et al. The association of oil ingestion with toxic oil syndrome in two convents. Am J Epidemiol 1987; 125: 907-12.
27. Finch WR, Rodnan GP, Buckingham RB, Prince RK, Winkelstein W. Bleiomycin-induced scleroderma. J Rheumatol 1980; 7: 651-9.
28. Silver RM, Heyes MP, Maize C, Quearry B, Vionnet-Fuasset MD, Sternberg EM, Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. N Engl J Med 1990; 322: 874-81.
29. Aeschlimann A, de Truchis P, Kahn MF. Scleroderma after therapy with appetite suppressants. Report on four cases. Scand J Rheumatol 1990; 19: 87-90.
30. Palestine RF, Millns JL, Spigel GT, Schroeter AL. Skin manifestations of pentazocine abuse. Am Acad Dermatol 1980; 2: 47-55.
31. Rose T, Nothjunge J, Schlote W. Familial occurrence of dermatomyositis and progressive scleroderma after injection of a local anaesthetic for dental treatment. Eur J Pediatr 1985; 143: 225-8.
32. Skouby AP. Sclerodermia-like picture following a single serum injection. Acta Med Scand 1949; 136: 51-5.
33. Silman AJ, Hicklin AJ, Black C. Geographical clustering of scleroderma in south and west London. Br J Rheumatol 1990; 29: 92-6.
34. Valesini G, Litta A, Bonavita MS, Luan FL, Purpura M, Mariani M et al. Geographical clustering of scleroderma in a rural area in the province of Rome. Clin Exp Rheumatol 1993; 11: 41-7.
35. Thompson AE, Pope JE. Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis. J Rheumatol 2002; 29: 1867-73.
36. Masi AT, Rodnan GP, Medsger TA, Altman RA, D'Angelo MA, Fries J et al. Preliminary criteria for classification systemic sclerosis (scleroderma). Arth Rheum 1980; 23: 581-90.
37. Englert HJ, Small-McMahon J, Davis K, O'Connor H, Chamber P, Brooks P. Scleroderma prevalence and mortality in Sydney 1974-1988. Aust NZ J Med 1999; 29: 42-50.
38. Chandran G, Smith M, Ahern MJ, Roberts-Thompson PJ. A study of scleroderma in South Australia: prevalence, subset characteristics and nailfold capillaroscopy. Aust NZ J Med 1995; 25: 688-94.